These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 18729350)

  • 1. Anxiolytic-like effects of N,N-dialkyl-2-phenylindol-3-ylglyoxylamides by modulation of translocator protein promoting neurosteroid biosynthesis.
    Da Settimo F; Simorini F; Taliani S; La Motta C; Marini AM; Salerno S; Bellandi M; Novellino E; Greco G; Cosimelli B; Da Pozzo E; Costa B; Simola N; Morelli M; Martini C
    J Med Chem; 2008 Sep; 51(18):5798-806. PubMed ID: 18729350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, Synthesis and Anxiolytic Activity Evaluation of N-Acyltryptophanyl- Containing Dipeptides, Potential TSPO Ligands.
    Gudasheva TA; Deeva OA; Mokrov GV; Dyabina AS; Yarkova MA; Seredenin SB
    Med Chem; 2019; 15(4):383-399. PubMed ID: 30457052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anxiolytic properties of a 2-phenylindolglyoxylamide TSPO ligand: Stimulation of in vitro neurosteroid production affecting GABAA receptor activity.
    Costa B; Da Pozzo E; Chelli B; Simola N; Morelli M; Luisi M; Maccheroni M; Taliani S; Simorini F; Da Settimo F; Martini C
    Psychoneuroendocrinology; 2011 May; 36(4):463-72. PubMed ID: 20728278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N,N-dialkyl-2-phenylindol-3-ylglyoxylamides. A new class of potent and selective ligands at the peripheral benzodiazepine receptor.
    Primofiore G; Da Settimo F; Taliani S; Simorini F; Patrizi MP; Novellino E; Greco G; Abignente E; Costa B; Chelli B; Martini C
    J Med Chem; 2004 Mar; 47(7):1852-5. PubMed ID: 15027878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and anxiolytic-like activity of 1-arylpyrrolo[1,2-a]pyrazine-3-carboxamides.
    Mokrov GV; Deeva OA; Gudasheva TA; Yarkov SA; Yarkova MA; Seredenin SB
    Bioorg Med Chem; 2015 Jul; 23(13):3368-78. PubMed ID: 25937237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TSPO-ligands prevent oxidative damage and inflammatory response in C6 glioma cells by neurosteroid synthesis.
    Santoro A; Mattace Raso G; Taliani S; Da Pozzo E; Simorini F; Costa B; Martini C; Laneri S; Sacchi A; Cosimelli B; Calignano A; Da Settimo F; Meli R
    Eur J Pharm Sci; 2016 Jun; 88():124-31. PubMed ID: 27094781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeated administration of AC-5216, a ligand for the 18 kDa translocator protein, improves behavioral deficits in a mouse model of post-traumatic stress disorder.
    Qiu ZK; Zhang LM; Zhao N; Chen HX; Zhang YZ; Liu YQ; Mi TY; Zhou WW; Li Y; Yang RF; Xu JP; Li YF
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():40-6. PubMed ID: 23624119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long Residence Time at the Neurosteroidogenic 18 kDa Translocator Protein Characterizes the Anxiolytic Ligand XBD173.
    Costa B; Da Pozzo E; Cavallini C; Taliani S; Da Settimo F; Martini C
    ACS Chem Neurosci; 2016 Aug; 7(8):1041-6. PubMed ID: 27385308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antidepressant-like and anxiolytic-like effects of YL-IPA08, a potent ligand for the translocator protein (18 kDa).
    Zhang LM; Zhao N; Guo WZ; Jin ZL; Qiu ZK; Chen HX; Xue R; Zhang YZ; Yang RF; Li YF
    Neuropharmacology; 2014 Jun; 81():116-25. PubMed ID: 24067925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancing neurosteroid synthesis--relationship to the pharmacology of translocator protein (18 kDa) (TSPO) ligands and benzodiazepines.
    Wolf L; Bauer A; Melchner D; Hallof-Buestrich H; Stoertebecker P; Haen E; Kreutz M; Sarubin N; Milenkovic VM; Wetzel CH; Rupprecht R; Nothdurfter C
    Pharmacopsychiatry; 2015 Mar; 48(2):72-7. PubMed ID: 25654303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TSPO ligand residence time: a new parameter to predict compound neurosteroidogenic efficacy.
    Costa B; Da Pozzo E; Giacomelli C; Barresi E; Taliani S; Da Settimo F; Martini C
    Sci Rep; 2016 Jan; 6():18164. PubMed ID: 26750656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and in vitro binding of N,N-dialkyl-2-phenylindol-3-yl-glyoxylamides for the peripheral benzodiazepine binding sites.
    Homes TP; Mattner F; Keller PA; Katsifis A
    Bioorg Med Chem; 2006 Jun; 14(11):3938-46. PubMed ID: 16480880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [PHARMACOLOGICAL STUDY OF NEW COMPOUNDS ACTING AS REGULATORS OF 18-KDA TRANSLOCATOR PROTEIN LIGANDS].
    Yarkov SA; Mokrov GV; Gudasheva TA; Yarkova MA; Seredenin SB
    Eksp Klin Farmakol; 2016; 79(1):7-11. PubMed ID: 27159950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Anxiolytic Etifoxine Binds to TSPO Ro5-4864 Binding Site with Long Residence Time Showing a High Neurosteroidogenic Activity.
    Costa B; Cavallini C; Da Pozzo E; Taliani S; Da Settimo F; Martini C
    ACS Chem Neurosci; 2017 Jul; 8(7):1448-1454. PubMed ID: 28362078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translocator protein ligands as promising therapeutic tools for anxiety disorders.
    Taliani S; Da Settimo F; Da Pozzo E; Chelli B; Martini C
    Curr Med Chem; 2009; 16(26):3359-80. PubMed ID: 19548867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of novel N1-methyl-2-phenylindol-3-ylglyoxylamides as a new chemotype of 18 kDa translocator protein-selective ligand suitable for the development of positron emission tomography radioligands.
    Pike VW; Taliani S; Lohith TG; Owen DR; Pugliesi I; Da Pozzo E; Hong J; Zoghbi SS; Gunn RN; Parker CA; Rabiner EA; Fujita M; Innis RB; Martini C; Da Settimo F
    J Med Chem; 2011 Jan; 54(1):366-73. PubMed ID: 21133364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anxiolytic-like effects of YL-IPA08, a potent ligand for the translocator protein (18 kDa) in animal models of post-traumatic stress disorder.
    Zhang LM; Qiu ZK; Zhao N; Chen HX; Liu YQ; Xu JP; Zhang YZ; Yang RF; Li YF
    Int J Neuropsychopharmacol; 2014 Oct; 17(10):1659-69. PubMed ID: 24763106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medicinal chemistry of indolylglyoxylamide TSPO high affinity ligands with anxiolytic-like effects.
    Simorini F; Marini AM; Taliani S; La Motta C; Salerno S; Pugliesi I; Da Settimo F
    Curr Top Med Chem; 2012; 12(4):333-51. PubMed ID: 22204487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The anxiolytic etifoxine activates the peripheral benzodiazepine receptor and increases the neurosteroid levels in rat brain.
    Verleye M; Akwa Y; Liere P; Ladurelle N; Pianos A; Eychenne B; Schumacher M; Gillardin JM
    Pharmacol Biochem Behav; 2005 Dec; 82(4):712-20. PubMed ID: 16388839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unbinding of Translocator Protein 18 kDa (TSPO) Ligands: From in Vitro Residence Time to in Vivo Efficacy via in Silico Simulations.
    Bruno A; Barresi E; Simola N; Da Pozzo E; Costa B; Novellino E; Da Settimo F; Martini C; Taliani S; Cosconati S
    ACS Chem Neurosci; 2019 Aug; 10(8):3805-3814. PubMed ID: 31268683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.